Shantou, Guangdong Province, first exported to the United States

According to the Guangdong Shantou Inspection and Quarantine Bureau on February 28, the Chinese patent medicine that was exported to the United States for the first time at Shantou Port has successfully entered the United States. As Chinese medicine becomes more and more popular overseas, Chinese medicine has become increasingly prosperous overseas. The Chinese patent medicine that was exported to the United States for the first time at Shantou Port was manufactured by Shantou Medicine Manufacturing Co., Ltd. in accordance with the formula (2,321 kg/25,995 US dollars), blood stagnation (3,585 kg/worth, US$40,425), and jade female frying. (243 kg/worth 2868 US dollars) Three varieties of traditional Chinese medicine powder products.

Considering that Sinopharm has a special significance for going abroad, Shantou Inspection and Quarantine Bureau actively assisted the company in accordance with relevant US laws and regulations after learning that a Chinese medicine product company intends to export the Chinese patent medicine powder to the United States. The Bureau instructs companies to conduct sample production in accordance with relevant requirements. After the inspection and quarantine department tests qualified samples for safety projects, the company will carry out mass production. This will not only reduce blindness, but also ensure product safety. At the time of export, the inspection and quarantine department of Shantou conducted a sample inspection on the finished products, and compared the test results with the “Data on Safety Standards of Chinese Medicinal Materials in Various Countries” to ensure compliance with the specific requirements of the “Statistical Data on the Safety of Chinese Medicinal Materials in Various Countries”. In the end, the Shantou Inspection and Quarantine Bureau carried out pest and quarantine inspection on the batch of products, issued a phytosanitary certificate and product inspection report, and the batch of Chinese patent medicines could be cleared in the United States.